The purpose of this study is to compare the usual treatment alone to using SBRT plus the usual treatment. Learn more about the NRG-LU008 trial or call the Reading Hospital Cancer Research Office at 484-628-8193.
NRG-LU008
Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (SBRT) Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
